Lupus erythematosus (systemic lupus) - Symptoms, Causes, Treatment & Prevention

```html

Overview

Systemic Lupus Erythematosus (SLE) is a chronic, autoimmune disease in which the body's immune system mistakenly attacks its own healthy tissues. The inflammation can involve the skin, joints, kidneys, brain, heart, lungs, and blood vessels.

Who it affects: SLE is most common in women of child‑bearing age (roughly 15–45 years). About 90 % of diagnosed patients are female, and the disease is three to nine times more prevalent in African‑American, Hispanic, Asian, and Native American populations compared with non‑Hispanic whites.

Prevalence: Worldwide estimates range from 20 to 150 cases per 100,000 people. In the United States, the CDC reports roughly 1.5 million adults living with lupus, equating to about 0.05 % of the population.<sup>[1] CDC, 2023</sup>

Symptoms

SLE is notorious for its “great imitator” reputation because symptoms can vary widely between individuals and may flare and remit over time. Below is a comprehensive list organized by organ system.

General / Constitutional

• Fatigue – persistent, often profound tiredness that is not relieved by rest.
• Fever – low‑grade fevers are common during flares.
• Weight loss – unintended loss, often secondary to decreased appetite.

Skin

• Butterfly (malar) rash – red, raised rash over the cheeks and bridge of the nose, sparing the nasolabial folds.
• Discoid rash – disc‑shaped, scaly plaques that can scar.
• Photosensitivity – rash or worsening of existing lesions after sun exposure.
• Hair loss (alopecia) – diffuse thinning or patchy loss, sometimes reversible.
• Oral or nasal ulcers – painless sores that do not bleed when brushed.

Musculoskeletal

• Arthralgia – joint pain without swelling, often symmetric.
• Non‑erosive arthritis – swelling and stiffness, typically affecting small joints of hands and wrists.
• Myo­pathy – muscle weakness, especially proximal muscles (shoulders, hips).

Renal (Kidneys)

• Lupus nephritis – proteinuria, hematuria, edema, hypertension; can progress to renal failure.

Cardiopulmonary

• Pleuritis – chest pain that worsens with deep breathing.
• Pericarditis – sharp chest pain, friction rub on exam.
• Libman‑Sacks endocarditis – small sterile vegetations on heart valves.
• Pulmonary hypertension – shortness of breath, fatigue.

Nervous System

• Headaches – often migraine‑like.
• Seizures – generalized or focal.
• Cognitive dysfunction – “brain fog,” memory lapses.
• Psychiatric manifestations – depression, anxiety.

Hematologic

• Anemia – fatigue, pallor.
• Leukopenia – low white blood cell count, increasing infection risk.
• Thrombocytopenia – low platelet count, easy bruising or bleeding.
• Antiphospholipid syndrome – blood clots, recurrent pregnancy loss.

Other

• Raynaud’s phenomenon – digits turn white/blue in response to cold.
• Dry eyes/mouth – secondary Sjögren‑like features.

Causes and Risk Factors

Exact cause remains unknown, but SLE results from a complex interaction of genetic, hormonal, environmental, and immunologic factors.

Genetic predisposition

• Family studies show a 5‑to‑10‑fold increased risk among first‑degree relatives.
• Specific HLA genes (e.g., HLA‑DR2, HLA‑DR3) and non‑HLA loci (PTPN22, STAT4) are associated with higher susceptibility.<sup>[2] NIH, 2022</sup>

Hormonal influences

• Estrogen is thought to enhance autoimmunity; disease onset often follows puberty, pregnancy, or hormone therapy.

Environmental triggers

• Ultraviolet (UV) radiation – can precipitate skin lesions and systemic flares.
• Infections – Epstein‑Barr virus, cytomegalovirus, and bacterial infections may trigger autoantibody production.
• Medications – certain drugs (e.g., procainamide, hydralazine, isoniazid) can cause drug‑induced lupus, a usually milder form that resolves after discontinuation.
• Smoking – linked to increased disease activity and poorer response to therapy.

Who is at higher risk?

• Women, especially of child‑bearing age.
• People of African, Hispanic, Asian, or Native American descent.
• Those with a family member diagnosed with lupus or another autoimmune disease.
• Individuals with a history of severe sun exposure or smoking.

Diagnosis

Because SLE mimics many conditions, diagnosis relies on a combination of clinical assessment and laboratory testing, guided by classification criteria such as the 2019 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) criteria.

Clinical assessment

• Detailed history of symptoms, flares, and triggers.
• Physical examination focusing on rash, joint swelling, organ involvement, and neurologic status.

Laboratory tests

• Antinuclear antibody (ANA) – positive in >95 % of patients; a screening test.
• Anti‑double‑stranded DNA (anti‑dsDNA) antibodies – highly specific; levels often correlate with renal disease activity.
• Anti‑Smith (anti‑Sm) antibodies – very specific but less common.
• Complement levels (C3, C4) – low during active disease.
• Complete blood count (CBC) – detects anemia, leukopenia, thrombocytopenia.
• Urinalysis & urine protein/creatinine ratio – screens for lupus nephritis.
• Antiphospholipid antibodies – lupus anticoagulant, anticardiolipin, β2‑glycoprotein I; assess clotting risk.

Imaging & specialty studies

• Chest X‑ray or CT – evaluates pleuritis, pneumonitis, or pulmonary hypertension.
• Echocardiogram – checks pericardial effusion or Libman‑Sacks endocarditis.
• Renal biopsy – gold standard for classifying lupus nephritis, guiding treatment.
• Skin biopsy – confirms discoid lesions when diagnosis is uncertain.

Treatment Options

Therapy is individualized based on organ involvement, disease severity, and patient preferences. The goals are to control inflammation, prevent organ damage, and maintain quality of life.

First‑line medications

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – for mild arthritis and serositis; use lowest effective dose to limit GI/renal side effects.
• Antimalarial drugs (Hydroxychloroquine) – cornerstone therapy for skin, joint, and constitutional symptoms; reduces flares and improves survival.<sup>[3] Mayo Clinic, 2023</sup>
• Corticosteroids – prednisone or methylprednisolone for rapid control of moderate‑to‑severe flares. Taper to the lowest effective dose to avoid long‑term complications.

Immunosuppressive agents

• Azathioprine – often used for maintenance after a flare.
• Mycophenolate mofetil (MMF) – preferred for class III/IV lupus nephritis.
• Methotrexate – effective for musculoskeletal disease, especially when NSAIDs are insufficient.
• Cyclophosphamide – given IV for severe organ involvement (e.g., proliferative nephritis, CNS disease).

Targeted biologic therapy

• Belimumab – monoclonal antibody against B‑lymphocyte stimulator (BLyS); approved for seropositive SLE with active disease despite standard therapy.
• Rituximab – anti‑CD20 B‑cell depletion; used off‑label for refractory nephritis or neuro‑lupus.

Adjunctive measures

• Anticoagulation – for patients with antiphospholipid syndrome or proven thrombosis.
• Vaccinations – annual influenza, pneumococcal, HPV, and COVID‑19 vaccines (non‑live formulations) to reduce infection risk.
• Bone protection – calcium, vitamin D, and bisphosphonates when long‑term steroids are used.

Lifestyle modifications

• Sun protection: broad‑spectrum sunscreen SPF 30+, protective clothing, and avoidance of peak UV hours.
• Smoking cessation.
• Balanced diet rich in omega‑3 fatty acids, antioxidants, and low in saturated fats.
• Regular, low‑impact exercise (walking, swimming) to maintain joint mobility and cardiovascular health.

Living with Lupus erythematosus (systemic lupus)

Managing SLE is a lifelong partnership between the patient, rheumatologist, and multidisciplinary team.

Daily management tips

• Medication adherence – set alarms or use pill organizers; never stop steroids abruptly.
• Symptom diary – record new rashes, joint pain, fatigue, or triggers to discuss at appointments.
• Regular monitoring – labs every 3‑6 months (CBC, CMP, urinalysis, complements) even when feeling well.
• Stress reduction – mindfulness, yoga, or counseling can lower flare frequency.
• Physical activity – Aim for at least 150 minutes of moderate aerobic exercise weekly; include strength training twice a week.
• Protect your kidneys – maintain adequate hydration, avoid NSAIDs >10 days without doctor oversight, and monitor blood pressure.
• Pregnancy planning – coordinate with a high‑risk obstetrician; disease should be stable (low steroid dose) before conception.

Support resources

• Lupus Foundation of America – patient education and peer‑support groups.
• American College of Rheumatology – find certified rheumatologists.
• Online forums (e.g., Inspire, Reddit r/lupus) – share experiences, but verify advice with a healthcare professional.

Prevention

Because SLE cannot be “prevented” in the traditional sense, the focus is on reducing modifiable risk factors and preventing flares.

• Sun avoidance – wear wide‑brim hats, UV‑blocking sunglasses, and UPF clothing.
• Smoking cessation – improves response to medications and lowers cardiovascular risk.
• Infection control – hand hygiene, timely vaccinations, and prompt treatment of infections.
• Medication review – avoid drugs known to precipitate lupus‑like syndromes unless absolutely necessary.
• Regular health checks – early detection of hypertension, dyslipidemia, and osteoporosis.

Complications

If SLE is inadequately controlled, chronic inflammation can damage multiple organ systems.

• Renal failure – lupus nephritis is a leading cause of end‑stage kidney disease.
• Cardiovascular disease – accelerated atherosclerosis; higher risk of myocardial infarction and stroke.
• Neuropsychiatric lupus – seizures, psychosis, or cognitive decline.
• Pulmonary complications – interstitial lung disease, pulmonary hypertension, or recurrent pleuritis.
• Hematologic abnormalities – severe anemia, thrombocytopenia, or life‑threatening clotting events.
• Infections – immunosuppressive therapy increases susceptibility to bacterial, viral, and fungal infections.
• Pregnancy loss – recurrent miscarriage, pre‑eclampsia, or preterm birth associated with antiphospholipid antibodies.

When to Seek Emergency Care

```